期刊
BIOTECHNOLOGY LETTERS
卷 31, 期 8, 页码 1167-1172出版社
SPRINGER
DOI: 10.1007/s10529-009-9989-1
关键词
Automation; Bioprocess; Cell; Scalability; Stem; Therapy
资金
- Engineering and Physical Sciences Research Council [EP/C534247/1] Funding Source: researchfish
Automation of cell culture processes is necessary to achieve scalable and reproducible manufacture of cell-based therapies. CTX0E03 is a near-clinic neural stem cell line for stroke therapy. The transfer of the CTX0E03 manufacture process from a manual to a completely automated process is demonstrated by (a) adapting the manual process to conform to the automated platform and (b) conducted a large scale (20 x T175 flasks) automated CTX0E03 expansion in accordance with the working bank to drug substance lot manufacture schedule. The automated lot was within the GMP release specification for viability, growth rate, nestin immunoreactivity and transcriptome equivalence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据